Viewing Study NCT05085366


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-28 @ 4:29 PM
Study NCT ID: NCT05085366
Status: TERMINATED
Last Update Posted: 2025-12-15
First Post: 2021-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Sponsor: ModernaTX, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-10-26
Start Date Type: ACTUAL
Primary Completion Date: 2025-11-04
Primary Completion Date Type: ACTUAL
Completion Date: 2025-11-04
Completion Date Type: ACTUAL
First Submit Date: 2021-10-07
First Submit QC Date: None
Study First Post Date: 2021-10-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-09
Last Update Post Date: 2025-12-15
Last Update Post Date Type: ESTIMATED